Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 19 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
News
Events
-
10x User Day – San Antonio
Building a complete understanding of the vast complexities of biology, from single cells to tissues and beyond, requires multiomic approaches. At 10x Genomics, we provide single cell, spatial, and in situ technologies that fuel scientific discoveries and drive exponential progress. Uncover molecular insights, dissect cell-type differences, detect novel cell subtypes and biomarkers, define gene regulatory interactions, and decipher spatial gene expression patterns. Join us for this event to explore how this spectrum of innovation can advance your research—learn more about Xenium In Situ, Visium CytAssist, and Chromium Single Cell Gene Expression Flex. -
Greehey CCRI Seminar Series, Fall ’23: David Libich, PhD. Greehey CCRI , – UT Health San Antonio
Presentation title: TBD